OIG Advisory Opinion: 25-04

    Unfavorable

    Device vendor pays hospitals’ exclusion-screening / monitoring fees

    Recorded opinion date:

    The commentary below transcribes Cabra's existing summary PDF. It preserves the original analysis, including its checklist and wording. The original PDF remains available below. Advisory opinions concern their particular facts and requestors; this commentary is not legal advice.

    What OIG Said

    OIG said paying compliance screening fees for your customers is remuneration that can look like buying referrals, not paying for services.

    ⚠OIG reviewed a proposal where a medical device company would pay a third-party company’s annual exclusion- screening and monitoring fee for each hospital/health system/ASC customer during onboarding and re- credentialing.

    ⚠OIG said the payments would be remuneration because they cover costs the customers otherwise would incur, and the customers are also referral sources for federally reimbursable device-related procedures.

    ⚠OIG found no safe harbor and concluded the arrangement presents anti-competitive and steering risk, since relieving customers of a financial burden could induce them to choose Requestor over competitors.

    ⚠OIG emphasized the per-customer fee structure creates a “gatekeeper” concern: customers might condition business on the vendor paying these fees, making the payments look like the price of access to referrals.

    Diligence Checklist

    What you need to be ready to show in diligence

    ✓Do not cover a customer’s operating/compliance costs (credentialing, monitoring, screening, admin subscriptions) unless you can clearly show why it’s not a referral inducement.

    ✓If any vendor assistance exists, document a legitimate commercial rationale that is independent of purchasing, volume, or access to cases.

    ✓Avoid per-customer or per-site payments that track with referral sources; those structures read like paying for access.

    ✓Keep agreements set in advance, tightly scoped, and arms-length, with no side deals tied to continued purchasing or exclusivity.

    ✓Be prepared to show what the customer pays vs. what the vendor pays and why that split is commercially reasonable.

    If you’re paying costs your customers should bear, and you can’t prove independence from purchasing decisions, this is exactly the profile OIG said will draw fire.

    Structure not diligence-ready?

    Cabra Consulting helps healthcare organizations make sure compensation and transaction structures are independently valued, clearly scoped, and defensible in diligence.

    Original PDF cover text

    UNFAVORABLE

    OIG WATCH 25-04

    Device vendor pays hospitals’ exclusion-screening / monitoring fees

    Cabra commentary publication date is not recorded in the existing source. No publication or revision date has been inferred from this HTML conversion.

    Source documents

    Preparing document preview…

    Ready to Move Forward?

    Let's explore how we can support your goals